Increased Expression of Foxj1 after Traumatic Brain Injury by Cui, Gang et al.
Increased Expression of Foxj1 after Traumatic Brain Injury
Gang Cui & Zhihua Yu & Zhen Li & Wei Wang & Ting Lu &
Chunhui Qian & Jiliang Li & Yunlin Ding
Received: 25 January 2011 /Accepted: 10 February 2011 /Published online: 24 February 2011
# The Author(s) 2011. This article is published with open access at Springerlink.com
Abstract Foxj1 is a member of the Forkhead/winged-helix
(Fox) family of transcription factors, which is required for
postnatal differentiation of ependymal cells and a subset of
astrocytes in the subventricular zone. The subpopulation of
astrocytes has the ability of self-renew and neurogenic
potential differentiated into astrocytes, oligodendrocytes,
and neurons. However, its expression and function in the
central nervous system lesion are not well understood. In
this study, we performed a traumatic brain injury (TBI)
model in adult rats and investigated the changed expression
of Foxj1 in the brain cortex. Western blot and immunohis-
tochemistry analysis showed that the expression of Foxj1
gradually increased, reached a peak at day 3 after TBI, and
declined during the following days. Double immunofluo-
rescence staining revealed that Foxj1 was co-expressed
with MAP-2 and GFAP. In addition, we detected that Ki67
had the co-localization with NeuN, GFAP, and Foxj1. All
our findings suggested that Foxj1 may be involved in the
pathophysiology of brain after TBI.
Keywords Foxj1.Traumatic brain injury.Rats.
Neurogenesis
Introduction
In modern times, traumatic brain injury (TBI) contributes
to a major cause of morbidity and mortality all over the
world, especially for children and young adults (Langlois
et al. 2006; Plesnila et al. 2007). More and more people
have been paying attention to the pathophysiology of the
trauma; however, to date, the mechanism of the inner
progress is not yet fully understood and the effect of the
therapeutics remains unsatisfied (Roberts et al. 1998;
McKee et al. 2005). Previous experiment studies in vivo
and in vitro have demonstrated that the event induced by
TBI triggers not only the primary injury which occurs
immediately after the damage, but also the second injury
which develops for a long term proximately several days
or weeks and plays an essential role in morbidity or
mortality (Nortje and Menon 2004;W a l k e re ta l .2009;
Zweckberger et al. 2006). All the steps involved in the
whole process will cause neuronal apoptosis, inflam-
matory reaction, and reactive astrogliosis, which lead to
consequently tissue loss, impaired regeneration, and
functional disabilities (Di Giovanni and Movsesyan
2005;M c G r a we ta l .2001; Raghupathi 2004). To
investigate the pathological mechanism and the cellular
and the molecular alteration after TBI appears important
for the value in order to improve the outcome in clinical
treatment.
Foxj1 is a member of the Forkhead/winged-helix
(Fox) family of transcription factors, which has a
conserved 100 amino acid DNA binding domain and
plays important roles in cilia formation of the respiratory,
reproductive, and central nervous systems (Clevidence et
al. 1993; Hackett et al. 1995; Brody et al. 2000).
Abnormal expression or targeted mutation of Foxj1 will
result in an absence of cilia in the tissues and a defect in
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Chen et al. 1998). Foxj1 suppresses T cell activity and
thus spontaneous autoimmunity, through the repression of
NF-κB activity (Srivatsan and Peng 2005). Foxj1 also
inhibits the humoral immune response in B cells; FOXJ1
deficiency in B cells results in spontaneous and accentu-
ated germinal center formation, implicated in the devel-
opment of pathogenic autoantibodies and accentuated
responses to immunizations (Lin et al. 2005).
Recent studies have shown that FoxJ1 is required for
postnatal differentiation of ependymal cells and a subset
of astrocytes in the subventricular zone (SVZ) and the
subpopulation of astrocytes has the ability of self-renew
and neurogenic potential differentiated into astrocytes,
oligodendrocytes and neurons (Jacquet and Salinas-
Mondragon 2009). We hypothesize that Foxj1 may be
involved in the pathophysiological and biochemical
progression after TBI, which is associated with the
outcome of brain function and neurogenesis induced by
injury.
In our study, we investigated the expression and the
distribution of Foxj1 in the rat brain after injury for the first
time. Our experiment is conducted to gain a brighter insight
into the physiologic functions of Foxj1 in the normal brain
and the cellular and molecular mechanisms underlying
central nerve lesion and repair.
Materials and Methods
Animals and Surgery
Male Sprague–Dawley rats (weighing 220–275 g) were
used in this experiment. After deeply anesthetized with
chloral hydrate (10% solution), the heads of the rats were
fixed in the stereotactic frame and a microknife was
inserted into the right cortex under the aseptic
condition 3 mm lateral parallel from the midline with an
antero-posterior surgical incision (5 mm long, 3 mm deep,
and 1 mm wide); thereafter, the scalps were sutured. Sham-
controlled rats were subjected the identical procedures to
experimental rats except for being inserted with the micro-
knife into the brain. After all the procedures, animals were
returned to their cages and allowed freely to get food and
water. Animals were housed under a 12 h light/dark cycle
and the room temperature (RT) was kept at 37±0.5.
Experimental animals (n=21) were killed at 12 h, 1, 3, 5,
7, 14, and 28 days after injury. Normal rats (n=3) and
sham-controlled rats (n=3) were sacrificed at 3 days. All
surgical and animal care procedures were carried out in
accordance with the Guide for Care and Use of Laboratory
Animals (National Research Council, 1996, USA) and were
approved by the Chinese National Committee to Use of
Experimental Animals for Medical Purposes, Jiangsu
Branch.
Western Blot
After given an overdose of chloral hydrate, rats were killed
at different time points post-operatively, and the cortex
tissue surrounding the wound (extending 3 mm to the
incision) as well as an equal part of the normal and sham-
controlled cortex were dissected out and stored at −80°C
until use. In order to prepare lysates, frozen cortex tissue
samples were weighed and minced with eye scissors in ice.
Then the samples were homogenized in lysis buffer (1%
sodium dodecyl sulfate (SDS), 1% Triton X-100, 50 mmol/
L Tris, 1% NP-40, pH 7.5, 5 mmol/L EDTA, 1% sodium
deoxycholate, 1 μg/ml leupeptin, 10 μg/ml aprotinin, and
1 mmol/L PMSF) and centrifuged at 12,000 rpm and 4°C
for 20 min to collect the supernatant. After determined
protein concentration with the Bradford assay (Bio-Rad),
protein samples were subjected to SDS-polyacrylamide gel
electrophoresis and transferred to a polyvinylidine diflour-
ide filter membrane. The membrane was blocked with 5%
milk without fat for 2 h and incubated with primary
antibody against Foxj1 (anti-mouse, 1:1,000; Santa Cruz)
or GAPDH (anti-rabbit, 1:1,000, Santa Cruz) at 4°C
overnight. At last, the membrane was incubated with
second antibody goat-anti-mouse or goat-anti-rabbit conju-
gated horseradish peroxidase (1:2,000, Southern-Biotech)
for 2 h and visualized using an enhanced chemilumines-
cence system (Pierce Company, USA).
Sections and Double Immunofluorescent Staining
After defined survival times, rats were terminally anesthe-
tized and perfused through the ascending aorta with 500 ml
of 0.9% saline, followed by 4% paraformaldehyde. After
that, the brains were removed and postfixed in the same
fixative for 3 h and then replaced with 20% sucrose for 2–
3 days, following 30% sucrose for 2–3d a y s .A f t e r
treatment with sucrose solutions, the tissues were embed-
ded in O.T.C. compound. Then, 10-μm frozen cross-
sections were prepared and examined. All sections were
first blocked with 10% normal serum-blocking solution
species the same as the secondary antibody, containing 3%
(w/v) bovine serum albumin (BSA), and 0.1% Triton X-100
and 0.05% Tween-20 2 h at RT in order to avoid unspecific
staining. Then, the sections were incubated with both rabbit
polyclonal primary antibodies for anti-MAP-2 (a marker of
neurons, 1:1,000; Santa Cruz), anti-GFAP (a marker of
astrocytes, 1:200; Sigma), and anti-Ki67 (a marker of cell
division, 1:300; Santa Cruz), and mouse monoclonal
primary antibodies for anti-Foxj1 (1:100; Santa Cruz),
anti-NeuN (a marker of neurons, 1:500; Chemicon), anti-
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sections were incubated with both primary antibodies
overnight at 4°C, followed by a mixture of FITC- and
TRITC-conjugated secondary antibodies for 2 h at 4°C. The
stained sections were examined with a Leica fluorescence
microscope (Germany).
Immunohistochemistry
We blocked the sections with confining liquid consisting of
10% goat serum, 1% BSA, 0.3% Triton X-100, and 0.15%
Tween-20 for 2 h at room temperature, then incubated with
anti-Foxj1 antibody (anti-mouse, 1:100, Santa Cruz) over-
night at 4°C. After incubation with the primary and the
second reagents as the second antibody for 20 and 30 min,
respectively, at 37°C, the reaction sections were incubated
with the liquid mixture (0.02% daminobenzidine tetrahy-
drochloride, 3% H2O2, and 0.1% PBS). Finally, the sections
were dehydrated and covered with coverslips. We examined
the sections and counted the cells with strong or moderate
brown staining, weak or no staining as positive or negative
Foxj1 cells, respectively, from each group at higher
magnified images. We took the average assays of each
group as the valuable results.
Quantitative Analysis
Cells double labeled for Foxj1 and the other phenotypic
markers used in the experiment were quantified. Sections
were double labeled for Foxj1 and MAP-2 and GFAP. To
identify the proportion of each phenotype-specific marker-
positivecellsexpressingFoxj1,aminimumof200phenotype-
specific marker-positive cells were counted adjacent to the
wound in each section. Then double labeled cells for Foxj1
and phenotype-specific markers were recorded. Two or three
adjacent sections per animal were sampled.
Statistical Analysis
All data were analyzed with Stata 7.0 statistical software. All
values were expressed as mean±SEM. One-way ANOVA
followed by the Tukey’s post hoc multiple comparison tests
was used for statistical analysis. P values less than 0.05 were
considered statistically significant. Each experiment con-
sisted of at least three replicates per condition.
Results
The Expression of Foxj1 in Brain by Western Blot
In order to investigate the temporal patterns of Foxj1
expression after TBI, Western blot was performed in this
study. In the cerebral cortex surrounding the injury, Foxj1
protein level was low in normal and sham cortex, and
increased at 12 h after TBI and peaked at day 3, then
gradually reduced thereafter; however, the expression of
Foxj1 at day 28 after injury was still higher than the sham
control. These data indicated that Foxj1 protein level had a
temporally change after TBI (Fig. 1a and b).
The Changed Distribution of Foxj1 in the Brain Cortex
after TBI
We used the coronal sections of the uninjured sham-
operation and day 3 after injury to assess the changed
distribution of the expression of Foxj1 by immunohisto-
chemistry. We could see that the immunostaining of Foxj1
deposited strongly in the plasmalemma adjacent to the
lesion site (Fig. 2e–g); however, a few positive immunos-
taining was found in the equal contralateral hemisphere
(Fig. 2 c ,d ,a n dg ) and the uninjured sham-operated
hemisphere (Fig. 2a and b). Further magnifications revealed
clearly the distribution and the morphous of the positive
immunostaining. The results suggested that the expression
of Foxj1 was apparently higher in the ipsilateral injured
brain on day 3 after TBI compared with the contralateral
hemisphere and the sham-operated hemisphere.
The Colocalization of Foxj1 with Different Cellular
Markers by Double Immunofluorescent Staining
To further determine the cell types expressing Foxj1 after
TBI, we used double labeling immunofluorescent staining
with cell-specific markers: MAP-2 (a marker of neurons)
and GFAP (a marker of astrocytes). We found that Foxj1
was expressed in neurons (Fig. 3a–c) and astrocytes
(Fig. 3g–i) and with a relatively low level in sham brain
(Fig. 3d–f and j–l). To identify the proportion of each
phenotype-specific marker-positive cells expressing Foxj1,
a minimum of 200 phenotype-specific marker-positive cells
were counted between sham and 3 days after TBI (Fig. 3m).
After injury, Foxj1 expression was increased significantly
in neurons and astrocytes at 3 days compared with sham
brain.
Cellular Proliferation in the Brains after TBI
To identify the proliferative cell types after TBI, we
performed double immunofluorescent staining with NeuN
(a marker of neurons), GFAP (a marker of astrocytes), and
Ki67 (a marker of cell division) in injured brain 3 days after
TBI. We also performed Foxj1 and Ki67 to investigate their
relationship. The results revealed that there were colocali-
zations between Neun and Ki67 (Fig. 4a–c), GFAP and
Ki67 (Fig. 4d–f), Foxj1, and Ki67 (Fig. 4g–i), that was to
J Mol Neurosci (2011) 45:145–153 147say neurons and astrocytes had proliferated after injury and
Foxj1 had the relationship with cell proliferation.
Discussion
TBI has been one of the leading causes of death and
disability in both industrialized and developing countries
(Djebaili et al. 2004; Lo et al. 2003) and results in a
significant society burden throughout the world (Langlois
et al. 2006; Marshall 2000; Teasdale and Graham 1998).
The pathophysiology of cerebral contusions is varied and
complicated, including complex temporal and regional
changes of cerebral blood flow and metabolism (Katayama
et al. 1998; Bullock et al. 1992), disruption of the blood–
brain barrier resulting in brain edema (Unterberg et al.
2004), and progressive neuronal cell death in pericontu-
sional tissue (Cervos-Navarro and Lafuente 1991). TBI
induces deleterious neuroinflammation, as proved by
edema, free radicals, cytokine production, induction of
nitric-oxide synthase and cyclooxygenase type 2, and
leukocyte infiltration (Xiao et al. 2008). Because a series
of inner mechanisms leading to the physiological and the
pathological alteration in the brain after injury have not
been understood clearly, there are currently no good
treatments that improve clinical outcome measures (Roberts
et al. 1998; McKee et al. 2005). In our study, we employed
a controlled stereotactic knife lesion model in adult rats to
investigate the cell mechanism after TBI.
We displayed the increased expression of Foxj1 in adult
rats’ brain after traumatic brain injury for the first time.
Western blot analysis showed that the expression of Foxj1
was significantly increased and peaked at 3 days after
injury. We also found that the staining of Foxj1 was
enhanced obviously in the ipisilateral brain cortex nearby
the lesion site compared to the conspilateral brain and the
sham-operated brain by immuohistochemical staining. By
double immunofluorescent staining, we observed that there
were co-localization of Foxj1 and MAP-2, as well as Foxj1
and GFAP. In addition, the co-localization of Foxj1 with
MAP-2 and GFAP was increased in the brain 3 days after
injury compared to the sham brain. In our experiment, the
important alteration of the expression of Foxj1 located in
cytoplasm in the brain after injury forcefully supported the
idea that Foxj1 was implicated in the central nervous
system pathophysiology after TBI. Our findings may
provide a crucial clue to learn the cellular and molecular
mechanisms underlying TBI.
Traumatic brain injury would lead to permanent motor,
cognitive and behavioral deficits, which are the result of
neural tissue loss and cell death (Paghupathi et al. 2000). In
response to the injury, the cells in the brain will produce
corresponding reactions to resist the injury and help to
recover the insulted functions. Neurons may be replenished
by neural stem cells in the dentate gyrus and subventricular
zones (Yagita et al. 2001; Peterson 2002). Astrocytes
proliferate possibly to support surviving neurons and
prevent further tissue damage through formation of the
glial scar (Smith et al. 2001). Microglia increase to get rid
of cellular debris and promote recovery of brain function
(Glulian et al. 1991). Recent studies have shown that the

























Fig. 1 Western blot showing
the temporal protein levels of
Foxj1 following traumatic brain
injury (TBI). Western blot was
performed to assess the protein
level of Foxj1 in the cortex
surrounding the wound at
different survival times after
TBI. The bar chart below
demonstrated the ratio of Foxj1
relative to GAPDH for each
time point. a Foxj1 protein level
was relatively lower in normal
and sham cortex, and peaked at
day 3, then gradually reduced. b
Semiquantitative analysis
(relative optical density) showed
the intensity of staining of Foxj1
to GAPDH for each time point.
The data are means±SEM (n=3,
*P<0.05, significantly different
from the sham-operated group)
148 J Mol Neurosci (2011) 45:145–153in different regions such as the sub-granular zone of the
dentate gyrus and the SVZ of the lateral ventricles
(Reynolds and Weiss 1992; Johansson et al. 1999;
Alvarez-Buylla et al. 2002; Doetsch et al. 1999; Palmer et
al. 1997). After injury, neurogenesis is stimulated in the
adult brain (Kunlin et al. 2010) and migration toward
pathology is the first critical step in stem cell engagement
during regeneration (Imitola et al. 2004). Neural stem cells
migrate through the parenchyma along nonstereotypical
routes in a precise directed manner across great distances to
injury sites in the central nervous system, where they could
engage niches harboring local transiently expressed repar-
ative signals (Imitola et al. 2004). Injury-induced neuro-
genesis has been observed across a broad range of injury
models in experimental animals and human patients. For




































































Fig. 2 The changed distribution
of Foxj1 in injured brain cortex
by immunohistochemical
staining. a, b We could observe
the staining of Foxj1 in the
sham-operated brain, and the
level was relatively lower. c, d
The same staining was found in
the equal contralateral
hemisphere of the injured brain;
however, the level was low as
the sham brain. e, f We could
see that the immunostaining of
Foxj1 deposited strongly
adjacent to the lesion site, in
addition the level was
significantly higher compared
with the sham and the
contralateral hemisphere of the
brain after TBI. g Quantitative
analysis of Foxj1 positive cells/
mm
2 between contralateral and
ipsilateral brains 3 days after
injury. Foxj1 was significantly
increased in the ipsilateral brain
at 3 days after TBI. Asterisk
indicated significant difference
at P<0.05 compared with
contralateral brain. Error bars
SEM. Scale bars: left columns
(a, c, e), 50 μm; right columns
(b, d, f), 10 μm


























































Fig. 3 Double immunofluorescence staining for Foxj1 and different
phenotype-specific markers in adult rat brain 3 days after TBI. The
sections from sham and injured brains 3 days after TBI were
immunostained with Foxj1 (green, b, e, h, k) and different cell
makers, such as MAP-2 (a marker of neurons, red, a, d) and GFAP (a
marker of astrocytes, red, g, j), and the co-localization of Foxj1 with
different phenotype-specific markers were visualized in the merged
images (c, f, i, l). a–c, g–i Immunostaining for Foxj1 with MAP-2 and
GFAP at 3 days after TBI; d–f, j–l Immunostaining for Foxj1 with
MAP-2 and GFAP in sham brain. m Quantitative analysis of different
phenotype-specific markers positive cells expressing Foxj1 (%) in
sham group and 3 days after injury. The change of Foxj1 was striking
in neurons and astrocytes; *, # indicate significant difference at P<
0.05 compared with the sham group. Error bars SEM. Scale bars
20 μm( a–l)
150 J Mol Neurosci (2011) 45:145–153neuronal precursor cells in the SVZ, followed by their
migration into ischemic brain regions, where they differen-
tiate and mature (Jin et al. 2001), in addition ectopic
neurogenesis has been observed in animal models in the
ipsilateral striatum of middle cerebral artery occlusion
(Arvidsson et al. 2002; Zhang et al. 2002)a n di n
degenerated hippocampal CA1 with global cerebral ische-
mia (Nakatomi et al. 2002; Bendel et al. 2005). The finding
that brain injury stimulates the production of neurogenesis
in the mammalian brain shows a role for this process in
brain repair.
Foxj1 is a member of the Fox family of transcription
factors, which plays an important role in cilia formation
(Clevidence et al. 1993; Hackett et al. 1995; Brody et al.
2000), left–right axis determination of organs (Brody et al.
2000;C h e ne ta l . ,1998), suppressing T cell activity
(Srivatsan and Peng 2005), inhibiting the humoral immune
response in B cells (Lin et al. 2005) and so on. Recent
studies found that Foxj1 is required for postnatal differen-
tiation of ependymal cells and a subset of astrocytes in the
SVZ, where these cells form a postnatal neural stem cell
niche (Jacquet and Salinas-Mondragon 2009). The findings
of the studies revealed that the subset of astrocytes
harvested from the SVZ generate neurospheres, which had
the capability of self-renew and had the potential to give
rise to neurons, astrocytes, and oligodendrocytes, thus
functionally resembling adult neural stem cells. In support
of this, recent studies have revealed that Foxj1 promoter-
active cells in the spinal canal and SVZ participate in
neurogenesis and gliogenesis in spinal cord injury and in
response to stroke (Meletis et al. 2008; Carlen et al. 2009).
Our study revealed that the expression of Foxj1 was
significantly increased in the rat brain after injury, which
supported the concept that Foxj1 may be involved in the
physiological and the pathological process in the injured
brain. Recent studies have displayed that Foxj1 is depended
in inducing the differentiation of a subset of astrocytes in
the subventricular zone, which can functionally act as adult
neural stem cells and give rise to neurons, astrocytes, and














Fig. 4 Double immunofluorescence staining for cellular proliferation
in the brains after TBI. Double immunofluorescence staining for
NeuN (a marker of neurons, green, a), GFAP (green, d), Foxj1 (green,
g), and Ki67 (a marker of cell division, red, b, e, h) in injured brain
cortex after TBI. In the rat brain 3 days after injury, there were co-
localization between NeuN and Ki67 (a–c), GFAP and Ki67 (d–f),
Foxj1 and Ki67 (g–i). Scale bars 20 μm( a–i)
J Mol Neurosci (2011) 45:145–153 151required for the differentiation of the cells acting as adult
neural stem cell which participate in neurogenesis and give
rise to neurons, astrocytes, and oligodendrocytes. These
cells may migrate to the lesion region by stimulation of
injury to compensate for the loss of neuronal function
caused by TBI. Our experiment may provide a novel
strategy for the treatment of CNS trauma in the field of
neurogenesis. Further studies are needed to confirm the
inherent mechanisms of the role of Foxj1 after brain injury.
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